PD-L1 overexpression (7, 8), mismatch repair deficiency (dMMR) (9–11), microsatellite instability-high status (MSI-H) (10–12), or high tumor mutational burden (TMB-H) (13–15) are the main predictive molecular biomarkers in these studies. The gene discussed is CD274; the disease is neoplasm.